Wordt geladen...
Licensing of Generic Medicines: Are There Any Challenges Left? A Pharmaceutical Regulatory Perspective
When an innovative product (innovator) is not covered anymore by intellectual property rights, cheaper equivalent medicinal products (generic products) may be marketed and used in clinical practice. The regulation of generic products is well-established, and is primarily based on standard rules for...
Bewaard in:
| Gepubliceerd in: | Sci Pharm |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Scientia Pharmaceutica
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4475802/ https://ncbi.nlm.nih.gov/pubmed/26171329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3797/scipharm.1312-10 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|